Navigation Links
Lexicon to Report Second Quarter Financial Results on July 30, 2013
Date:7/23/2013

THE WOODLANDS, Texas, July 23, 2013 /PRNewswire/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on discovering breakthrough treatments for human disease, will release its second quarter 2013 financial results on Tuesday, July 30, 2013 before the financial markets open.  Lexicon management will hold a conference call and webcast to discuss clinical development progress and financial results for the second quarter at 11:00 a.m. Eastern Time on July 30, 2013. 

The dial-in number for the conference call is 888-645-5785 (within the US/Canada) or 970-300-1531 (international).  The conference ID for all callers is 22881223.  Investors can access a live webcast of the call at www.lexpharma.com.  An archived version of the webcast will be available on the website through August 30, 2013.

About Lexicon
Lexicon is a biopharmaceutical company focused on discovering breakthrough treatments for human disease.  Lexicon currently has multiple drug programs in clinical development for diabetes, irritable bowel syndrome, carcinoid syndrome and other indications, all of which were discovered by Lexicon's research team.  Lexicon has used its proprietary gene knockout technology to identify more than 100 promising drug targets.  Lexicon has focused drug discovery efforts on these biologically-validated targets to create its extensive pipeline of clinical and preclinical programs.  For additional information about Lexicon and its programs, please visit www.lexpharma.com.

Safe Harbor Statement
This press release contains "forward-looking statements," including statements relating to Lexicon's growth and futur
'/>"/>

SOURCE Lexicon Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Lexicon to Provide First Quarter 2012 Financial Results
2. Lexicon Pharmaceuticals Reports On Clinical Program Status And 2012 First Quarter Results
3. Lexicon Receives Funding for Phase 2 Clinical Trial of LX4211 in Type 1 Diabetes
4. Lexicon Pharmaceuticals to present at the Jefferies 2012 Global Healthcare Conference
5. Lexicon Presents Data Regarding the Mechanism of Action and Safety of LX4211 at American Diabetes Association Meeting
6. Lexicon Announces Positive Results of LX4211 Phase 2b Trial For Type 2 Diabetes
7. Lexicon Announces Publication of Results of Two Studies of LX4211 in Patients with Type 2 Diabetes in the Journal Clinical Pharmacology & Therapeutics
8. Lexicon to Provide Second Quarter 2012 Financial Results
9. Lexicon Pharmaceuticals Reports On Clinical Program Status And 2012 Second Quarter Results
10. Lexicon Pharmaceuticals To Present At The Wedbush PacGrow 2012 Management Access Conference
11. Lexicon Pharmaceuticals Reports Preliminary Results From Two Phase 1 Studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... WEST ORANGE , N.J. and NEW BRUNSWICK, N.J., Sept. ... formal affiliation agreement that allows Kessler Foundation and ... to advance biomedical research, education and patient care ... , president and chief executive officer of Kessler ... of New Jersey Health Foundation. "The ...
(Date:9/30/2014)... , Sept. 30, 2014 The Eastern European ... established medical-device providers as well as new medical-device manufacturers ... while simultaneously looking at ways to reduce the cost ... distributors is one of the effective means to achieve ... distribution market in Eastern European and provides profiles of ...
(Date:9/30/2014)... Ariz. , Sept. 30, 2014 Passport ... North America , has launched FluFree.com, a website ... flu vaccinations. For 20 years, Passport Health ... including the flu. The launch of FluFree.com is designed ... vaccination and the number of people who actually chose ...
Breaking Medicine Technology:Kessler Foundation Partners with New Jersey Health Foundation To Start Innovative Companies To Change the Lives of People with Disabilities 2Medical Technologies Distributor Profiles in Eastern Europe 2Medical Technologies Distributor Profiles in Eastern Europe 3Passport Health Launches FluFree.com - Aims To Improve Flu Vaccination Rates and Fulfill Growing Public Health Priority 2Passport Health Launches FluFree.com - Aims To Improve Flu Vaccination Rates and Fulfill Growing Public Health Priority 3
... 26 BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ... Pharmaceuticals, Inc. (Huxley), which has rights to a ... the rare autoimmune disease Lambert Eaton Myasthenic Syndrome ... Products for Human Use of the European Medicines ...
... PINNACLE Network (TM) Links Thousands of Clinical ... Excellence , WASHINGTON, Oct. 26 The ... of the PINNACLE Network(TM), the first-ever registry-based cardiovascular ... each other and to the ACC,s National Cardiovascular ...
Cached Medicine Technology:BioMarin Acquires Huxley Pharmaceuticals, Inc. 2BioMarin Acquires Huxley Pharmaceuticals, Inc. 3BioMarin Acquires Huxley Pharmaceuticals, Inc. 4BioMarin Acquires Huxley Pharmaceuticals, Inc. 5BioMarin Acquires Huxley Pharmaceuticals, Inc. 6American College of Cardiology Launches the Nation's First Registry-Based Cardiovascular Practice Network 2American College of Cardiology Launches the Nation's First Registry-Based Cardiovascular Practice Network 3
(Date:9/30/2014)... Next to lung cancer, breast cancer is the leading ... American Cancer Society. That,s why so many medical professionals ... are imperfect at best: only a minority of suspicious ... results in lots of needless worry for women and ... of additional tests, including ultrasounds and biopsies. , ...
(Date:9/30/2014)... Utah (PRWEB) September 30, 2014 A new ... Ohio State University studied the impact of stress on metabolism ... burger and french fries from a fast food restaurant, about ... woman’s resting metabolism for 20 minutes every hour for 7 ... Results showed that women who had experienced a stressful event ...
(Date:9/30/2014)... Calif., Sept. 30, 2014 Research by UC Irvine ... functions, shedding light on a vital process that determines ... In the online version of Nature Immunology , ... and other Institute for Immunology colleagues describe a critical ... released into the bloodstream. , A T cell is ...
(Date:9/30/2014)... Vegas, NV (PRWEB) September 30, 2014 ... as a free introduction to SurvivalLife.com along with a free ... caught the attention of Shane Michaels, prompting an investigative review. ... most well-known people in the survival and preparation niche, and ... all of the great classes and survival products that Joe ...
(Date:9/30/2014)... CA (PRWEB) September 30, 2014 ... providers in Turkey has gone up more than 79 ... The medical tourism company also reported total revenue tripled ... 2012. , The company’s professional strategy has allowed them ... — ultimately designed for patient comfort and privacy — ...
Breaking Medicine News(10 mins):Health News:'Virtual breast' could improve cancer detection 2Health News:NutriGold Urges Every Woman To Read a Recent Study About Diet and Stress 2Health News:NutriGold Urges Every Woman To Read a Recent Study About Diet and Stress 3Health News:UCI study uncovers important process for immune system development 2Health News:EverStryke: Review Exposes Joe Marshall’s Permanent Match Survival Product 2Health News:VisitandCare.com Announces Record Demand for Plastic Surgery in Turkey 2Health News:VisitandCare.com Announces Record Demand for Plastic Surgery in Turkey 3Health News:VisitandCare.com Announces Record Demand for Plastic Surgery in Turkey 4
... mates, study finds , MONDAY, June 29 (HealthDay News) -- ... according to a U.S. study that challenges the belief that ... undergraduates for speed-dating events. In half the events, men rotated ... location. The roles were reversed in the other events. , ...
... , ... Institute on Drug Abuse (VIDA) working in collaboration with colleagues at Vector Tobacco, Inc. and ... a better chance at kicking the tobacco habit. , ... Manhasset, NY (Vocus) June 29, 2009 -- Scientists at ...
... Complimentary Continuing Education Monograph for Healthcare Professionals , ... is an autosomal dominant disease affecting between 4,000 and ... attacks of intense localized edema involving the skin, airway, ... or plasmin inhibitors has been the mainstay of HAE ...
... Finnish Academy Professors Lauri Aaltonen and Jussi Taipale have identified ... human genome increases the risk of colorectal cancer. ... variant occurring in chromosome 8, which in itself causes only ... is carried by 75% of people of European origin and ...
... group of scientists working in Indiana University,s School of ... than $2.2 million from the National Institutes of Health ... grant from the National Eye Institute, an arm of ... elite group of vision research centers in the nation. ...
... Germany and ST. LOUIS, June 29 Bayer CropScience ... their respective herbicide tolerance traits in rapeseed/canola on a ... seed businesses. Canola is a form of rapeseed ... , Under the terms of this global agreement, ...
Cached Medicine News:Health News:Maybe Men Aren't So Picky After All 2Health News:News from the Latest Issue of Molecular Medicine Kicking The Habit - It's In The Genes 2Health News:Changing Paradigms in Hereditary Angioedema: Pathophysiology, Diagnosis and Treatment 2Health News:Risk of cancer 2Health News:IU School of Optometry named national vision research center 2Health News:IU School of Optometry named national vision research center 3Health News:Bayer CropScience and Monsanto Sign Cross Licensing Agreement on Herbicide Tolerance Traits in Rapeseed/Canola 2Health News:Bayer CropScience and Monsanto Sign Cross Licensing Agreement on Herbicide Tolerance Traits in Rapeseed/Canola 3
Designed to fit a variety of 250 L and 300 ul multi-channel pipettors, this tip offers a secure fit and extra space for repeat pipetting....
... Finntip Filters are ideal for ... or for any work where ... are designed for pipetting DNA/RNA ... and other. For applications requiring ...
Hydrophobic PE filter without self-sealing additives, permits sample recovery after accidental over-pipetting. All filters are sterile (to USP, DAB, Ph.Eur. standards) and PCR clean (free from human ...
... Resistant Tips offer a safe alternative to ... designed for applications such as PCR(a), pipetting ... ART Tips are excellent for tissue culture, ... ART Tips prevent aerosol contaminants and liquids ...
Medicine Products: